Search the webpage

Category: Neuroprotection / glioprotection

An assessment and prediction of study compound-induced neuroprotection / toxicity on the rat primary cortical neurons in vitro.

SUMMARY

Cells

Rat primary cortical neurons

Oxidative stress inducer

tert-butyl hydroperoxide (tBHP) at concentrations 0-40 µM

Positive control

(±)-6-Hydroxy-2,5,7,8- tetramethylchromane-2-carboxylic acid (Trolox) 1000 µM

Indicator and detection

Indicator: resazurin (7-Hydroxy-3H-phenoxazin-3-one-10-oxide) dye is irreversibly reduced to highly fluorescent metabolite resorufin (7-Hydroxy-3H-phenoxazin-3-one);

 

Detection: after 2 h exposure to resazurin, the amount of resorufin is measured at 560 nm (ex), 590 nm (em) by using Cytation 3 multi-mode reader (BioTek Instruments, Winooski, VT, USA).

Please contact us, if you would like to receive more information: info@experimentica.com

IMAGES

Rat primary cortical neurons

Immunostaining of the rat primary cortical neurons (in red) counterstained with cellular nuclear marker DAPI (in blue).

SELECTED PUBLICATIONS

  • Kaja S, Duncan RS, Longoria S, Hilgenberg JD, Payne AJ, Desai NM, Parikh RA, Burroughs SL, Gregg EV, Goad DL, Koulen P. Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors. Neuroscience. 2011,175:281-291. doi: 10.1016/j.neuroscience.2010.11.010.

REFERENCES

  1. Burroughs SL, Duncan RS, Rayudu P, Kandula P, Payne AJ, Clark JL, Koulen P, Kaja S. Plate reader-based assays for measuring cell viability, neuroprotection and calcium in primary neuronal cultures. J Neurosci Methods. 2012,203(1):141-145. doi: 10.1016/j.jneumeth.2011.09.007.

Leave a Comment

LATEST NEWS

Experimentica Ltd. Sponsors the 2018 SILK-Elsemay Björn Symposium

News
Experimentica Ltd. is pleased to announce its co-sponsorship and participation in this year’s SILK - Elsemay Björn Symposium. This yearly ... Read More

Check out our new publication on the mouse dry-eye disease model

An alpha1 adrenergic agonist shows preclinical efficacy in a preclinical model for dry eye syndrome ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!